These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16995746)

  • 1. Elucidation of characteristic structural features of ligand binding sites of protein kinases: a neural network approach.
    Niwa T
    J Chem Inf Model; 2006; 46(5):2158-66. PubMed ID: 16995746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional classification of protein kinase binding sites using Cavbase.
    Kuhn D; Weskamp N; Hüllermeier E; Klebe G
    ChemMedChem; 2007 Oct; 2(10):1432-47. PubMed ID: 17694525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence and structural analysis of kinase ATP pocket residues.
    Vulpetti A; Bosotti R
    Farmaco; 2004 Oct; 59(10):759-65. PubMed ID: 15474052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communication pathways between the nucleotide pocket and distal regulatory sites in protein kinases.
    Wong L; Jennings PA; Adams JA
    Acc Chem Res; 2004 May; 37(5):304-11. PubMed ID: 15147171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel computational analysis of ligand-induced conformational changes in the ATP binding sites of cyclin dependent kinases.
    Subramanian J; Sharma S; B-Rao C
    J Med Chem; 2006 Sep; 49(18):5434-41. PubMed ID: 16942017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
    Chuaqui C; Deng Z; Singh J
    J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. kinDOCK: a tool for comparative docking of protein kinase ligands.
    Martin L; Catherinot V; Labesse G
    Nucleic Acids Res; 2006 Jul; 34(Web Server issue):W325-9. PubMed ID: 16845019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding.
    Sheinerman FB; Giraud E; Laoui A
    J Mol Biol; 2005 Oct; 352(5):1134-56. PubMed ID: 16139843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
    Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemometrical classification of ephrin ligands and Eph kinases using GRID/CPCA approach.
    Myshkin E; Wang B
    J Chem Inf Comput Sci; 2003; 43(3):1004-10. PubMed ID: 12767159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis.
    Huang D; Zhou T; Lafleur K; Nevado C; Caflisch A
    Bioinformatics; 2010 Jan; 26(2):198-204. PubMed ID: 19942586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases.
    Cox KJ; Shomin CD; Ghosh I
    Future Med Chem; 2011 Jan; 3(1):29-43. PubMed ID: 21428824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study.
    Panigrahi SK
    Amino Acids; 2008 May; 34(4):617-33. PubMed ID: 18180869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the ATP-binding domain of human fructosamine 3-kinase-related protein by affinity labelling with 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
    Payne LS; Brown PM; Middleditch M; Baker E; Cooper GJ; Loomes KM
    Biochem J; 2008 Dec; 416(2):281-8. PubMed ID: 18637789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of protein kinases by ATP-STD NMR spectroscopy.
    McCoy MA; Senior MM; Wyss DF
    J Am Chem Soc; 2005 Jun; 127(22):7978-9. PubMed ID: 15926798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation.
    Romaker D; Schregel V; Maurer K; Auerochs S; Marzi A; Sticht H; Marschall M
    J Med Chem; 2006 Nov; 49(24):7044-53. PubMed ID: 17125257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
    Bogoyevitch MA; Fairlie DP
    Drug Discov Today; 2007 Aug; 12(15-16):622-33. PubMed ID: 17706543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and comparison of ligand-binding sites derived from grid-mapped knowledge-based potentials.
    Hoppe C; Steinbeck C; Wohlfahrt G
    J Mol Graph Model; 2006 Mar; 24(5):328-40. PubMed ID: 16260161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding site similarity analysis for the functional classification of the protein kinase family.
    Kinnings SL; Jackson RM
    J Chem Inf Model; 2009 Feb; 49(2):318-29. PubMed ID: 19434833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.